Form 8-K EXELIXIS, INC. For: Oct 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Exelixis (EXEL) PT Raised to $29 at Stephens
October 30, 2024 6:27 AM EDTStephens analyst Sudan Loganathan raised the price target on Exelixis (NASDAQ: EXEL) to $29.00 (from $23.00) while maintaining a Equal Weight rating.
The analyst comments "EXEL reported 3Q24 financial results yesterday (10/29/2024) after market close and provided regulatory and business updates. Key highlights on the... More
Exelixis (EXEL) PT Raised to $38 at Citi
October 30, 2024 5:47 AM EDTCiti analyst David Lebowitz raised the price target on Exelixis (NASDAQ: EXEL) to $38.00 (from $31.00) while maintaining a Buy rating.
The analyst comments "Exelixis reported 3Q24 financial results, beating consensus on top-line revenue and GAAP EPS due to continued strength of cabozantinib. Total... More
Exelixis (EXEL) Tops Q3 EPS by 13c, Tops on Revenue; Offers FY24 Revenue Guidance
October 29, 2024 4:09 PM EDTExelixis (NASDAQ: EXEL) reported Q3 EPS of $0.47, $0.13 better than the analyst estimate of $0.34. Revenue for the quarter came in at $539.5 million versus the consensus estimate of $489.77 million.
GUIDANCE:
Exelixis sees FY2024 revenue of $2.15-2.2 billion, versus the consensus of $2.05... More
